Inventor · disambiguated record
Jay Marshall Feingold
Also filed as: FEINGOLD JAY MARSHALL
7 granted patents·12 pending applications·31 citations·filing 2003–2022
82Inventor score
Top patents by PatentIndex Score
19 records- 0185US11938192B2Dosage regimes for the administration of an anti-CD19 ADCADC THERAPEUTICS SA·Filed 2022·Granted Mar 26, 2024·1 cites·19 claims
- 0285US11318211B2Dosage regimes for the administration of an anti-CD19 ADCADC THERAPEUTICS SA·Filed 2018·Granted May 3, 2022·4 cites·16 claims
- 0385US7727968B2Combination therapy for the treatment of acute leukemia and myelodysplastic syndromeWYETH LLC·Filed 2007·Granted Jun 1, 2010·5 cites·20 claims
- 0482US11596696B2Combination therapy with an anti-CD25 antibody-drug conjugateADC THERAPEUTICS SA·Filed 2018·Granted Mar 7, 2023·3 cites·13 claims
- 0581US8791097B2Anti-tumor activity of CCI-779 in papillary renal cell cancerDUKART GARY·Filed 2008·Granted Jul 29, 2014·6 cites·14 claims
- 0678US11426467B2Dosage regimes for the administration of an anti-CD25 ADCADC THERAPEUTICS SA·Filed 2018·Granted Aug 30, 2022·1 cites·25 claims
- 0774US8338456B2Cut-point in PTEN protein expression that accurately identifies tumors and is predictive of drug response to a pan-ErbB inhibitorCOUGHLIN CHRISTINA MARIE·Filed 2011·Granted Dec 25, 2012·11 cites·20 claims
- 0869US2022170107A1Phosphatidylinositol-3-kinase pathway biomarkersWYETH LLC·Filed 2021·Application pending·0 cites
- 0968US2023106885A1Dosage regimeADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 1066US2023149556A1Combination therapyADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 1165US2023039868A1Dosage regimesADC THERAPEUTICS SA·Filed 2022·Application pending·0 cites
- 1258US2020405873A1Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1357US2004152632A1Combination therapy for the treatment of acute leukemia and myelodysplastic syndromeWYETH CORP·Filed 2003·Application pending·0 cites
- 1455US2019271047A1Phosphatidylinositol-3-kinase pathway biomarkersWYETH LLC·Filed 2019·Application pending·0 cites
- 1555US2020405879A1Combination therapyADC THERAPEUTICS SA·Filed 2018·Application pending·0 cites
- 1651US2019015524A1Pyrrolobenzodiazepine-antibody conjugatesMEDIMMUNE LTD·Filed 2015·Application pending·0 cites
- 1750US2022111065A1Molecular adjuvantADC THERAPEUTICS SA·Filed 2019·Application pending·0 cites
- 1846US2016222467A1Phosphatidylinositol-3-kinase pathway biomarkersWYETH LLC·Filed 2016·Application pending·0 cites
- 1941US2013189274A1Phosphatidylinositol-3-kinase pathway biomarkersBERKENBLIT ANNA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay Marshall Feingold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →